Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- TME -6.9%, ONON -6.5%, HBM -4.3%, MRSN -3.5%, KGS -2.7%, HD -2.4%, SLF -2%, DHT -1.2%, SE -1.2%, CATX -0.9%
Other news:
- SYRS -64.9% (provides update on SELECT-AML-1 Phase 2 Clinical Trial)
- RILY -10.8% (to delay 10-Q filing)
- RXO -5.1% (private placement)
- WES -3.8% (prices secondary offering of common units for gross proceeds of $685.9 mln)
- AHR -3.7% (files mixed shelf and stock offering)
- SCNI -3.2% (loan restructuring agreement with European Investment Bank; converting approximately $29 million of debt to preferred equity convertible into 19.5% common equity)
- JBLU -2.9% (prices offering of $400 mln of 2.50% convertible senior notes due 2029)
- FRST -2.3% (to delay 10-Q filing)
- UTZ -2.1% (Completes Acquisition of Strategic Distribution Rights of National Food Corp)
- ARDX -2.1% (detailed Commercial Supply Agreement with Catalent Pharma)
- SLF -2% (to renew NCIB to repurchase 15 mln shares)
- INO -1.9% (entered into $60 mln Equity Distribution Agreement with Oppenheimer)
- OXY -1.7% (stock offering)
- VCTR -1.6% (reports total AUM)
- QSR -1.2% (prices secondary offering)
Analyst comments:
- ASO -1.2% (downgraded to Hold from Buy at TD Cowen)
- CYTK -1.1% (downgraded to Neutral from Buy at Goldman)